World Bank Group consultant, Colorado Springs, Colorado, United States of America.
Health Services and System Research Program, Duke-NUS Medical School, Singapore.
East Mediterr Health J. 2022 Apr 28;28(4):296-301. doi: 10.26719/emhj/22.015.
The prevalence of noncommunicable diseases (NCDs) has been increasing in Saudi Arabia.
Our objective was to estimate the effect of NCDs on direct medical costs and workforce productivity in Saudi Arabia.
To estimate direct medical costs, we estimated the unit cost of treating 10 NCDs, then multiplied the unit cost by disease prevalence and summed across diseases. To estimate workforce productivity losses, we multiplied gross domestic product per person in the labour force by the loss in productivity from each NCD and the prevalence in the labour force of each NCD.
We estimated annual direct medical costs of 11.8 billion international dollars (Int$) for the 10 NCDs assessed (13.6% of total annual health expenditure). We estimated workforce productivity losses of Int$ 75.7 billion (4.5% of gross domestic product).
The economic burden of NCDs in Saudi Arabia - particularly the effect on worker productivity - is substantial.
非传染性疾病（NCDs）在沙特阿拉伯的患病率一直在上升。
我们的目的是估计 NCDs 对沙特阿拉伯直接医疗成本和劳动力生产力的影响。
为了估计直接医疗成本，我们估计了治疗 10 种 NCD 的单位成本，然后将单位成本乘以疾病的患病率，并对所有疾病进行求和。为了估计劳动力生产力损失，我们将劳动力人均国内生产总值乘以每种 NCD 的生产力损失和每种 NCD 在劳动力中的患病率。
我们估计了所评估的 10 种 NCD 的年度直接医疗费用为 118 亿美元（Int$）（占总年度卫生支出的 13.6%）。我们估计劳动力生产力损失为 757 亿美元（Int$）（占国内生产总值的 4.5%）。
NCDs 在沙特阿拉伯的经济负担 - 特别是对工人生产力的影响 - 是巨大的。
